Effects of chronic dopamine D2R agonist treatment and polysialic acid depletion on dendritic spine density and excitatory neurotransmission in the mPFC of adult rats

Neural Plasticity

Volumn 2016, Issue , 2016, Pages

  Castillo Gómez, Esther ^a   Varea, Emilio ^a   Blasco Ibáñez, José Miguel ^a   Crespo, Carlos ^a   Nacher, Juan ^a,b,c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR STIMULATING AGENT; NERVE CELL ADHESION MOLECULE; POLYSIALIC ACID; VESICULAR GLUTAMATE TRANSPORTER 1; 2-(N-PHENETHYL-N-PROPYL)AMINO-5-HYDROXYTETRALIN; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; ENDO-ALPHA-SIALIDASE; GLYCOSIDASE; NERVE CELL ADHESION MOLECULE L1; PHENETHYLAMINE DERIVATIVE; SIALIC ACID DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; DENDRITIC SPINE; IMMUNOREACTIVITY; INFRALIMBIC CORTEX; LONG TERM CARE; MALE; MEDIAL PREFRONTAL CORTEX; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; REGULATORY MECHANISM; AGONISTS; ANIMAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALS; DENDRITIC SPINES; DOPAMINE AGONISTS; GLYCOSIDE HYDROLASES; MALE; NEURAL CELL ADHESION MOLECULE L1; PHENETHYLAMINES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SIALIC ACIDS; SYNAPTIC TRANSMISSION;

EID: 84964807347     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2016/1615363     Document Type: Article

References (43)

1. D. Durstewitz and J. K. Seamans, "The dual-state theory of prefrontal cortex dopamine function with relevance to catecholo- methyltransferase genotypes and schizophrenia, " Biological Psychiatry, vol. 64, no. 9, pp. 739-749, 2008.
2. S. Gee, I. Ellwood, T. Patel, F. Luongo, K. Deisseroth, and V. S. Sohal, "Synaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex, " The Journal of Neuroscience, vol. 32, no. 14, pp. 4959-4971, 2012.
3. D. A. Lewis and G. Gonzalez-Burgos, "Neuroplasticity of neocortical circuits in schizophrenia, " Neuropsychopharmacology, vol. 33, no. 1, pp. 141-165, 2007.
4. A. F. T. Arnsten, "Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia, " International Journal of Developmental Neuroscience, vol. 29, no. 3, pp. 215-223, 2011.
5. Y.-C. Wang, U.-C. Ho, M.-C. Ko, C.-C. Liao, and L.-J. Lee, "Differential neuronal changes in medial prefrontal cortex, basolateral amygdala and nucleus accumbens after postweaning social isolation, " Brain Structure and Function, vol. 217, no. 2, pp. 337-351, 2012.
6. H.-D. Wang and A. Y. Deutch, "Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment, " Neuropsychopharmacology, vol. 33, no. 6, pp. 1276-1286, 2008.
7. L. Bonfanti, "PSA-NCAM in mammalian structural plasticity and neurogenesis, " Progress in Neurobiology, vol. 80, no. 3, pp. 129-164, 2006.
8. E. Gascon, L. Vutskits, and J. Z. Kiss, "Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons, " Brain Research Reviews, vol. 56, no. 1, pp. 101-118, 2007.
9. U. Rutishauser, "Polysialic acid in the plasticity of the developing and adult vertebrate nervous system, " Nature Reviews Neuroscience, vol. 9, no. 1, pp. 26-35, 2008.
10. E. Varea, J. Nacher, J. M. Blasco-Ibanez et al., "PSA-NCAM expression in the rat medial prefrontal cortex, " Neuroscience, vol. 136, no. 2, pp. 435-443, 2005.
11. M. A. Gomez-Climent, R. Guirado, E. Castillo-Gomez et al., "The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) is expressed in a subpopulation of mature cortical interneurons characterized by reduced structural features and connectivity, " Cerebral Cortex, vol. 21, no. 5, pp. 1028-1041, 2011.
12. E. Castillo-Gomez, M. A. Gomez-Climent, E. Varea et al., "Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefrontal cortex of adult rats, " Experimental Neurology, vol. 214, no. 1, pp. 97-111, 2008.
13. E. Castillo-Gomez, E. Varea, J. M. Blasco-Ibanez, C. Crespo, and J. Nacher, "Polysialic acid is required for dopamine D2 receptor-mediated plasticity involving inhibitory circuits of the rat medial prefrontal cortex, " PLoS ONE, vol. 6, no. 12, Article ID e29516, 2011.
14. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press/Elsevier, London, UK, 6th edition, 2007.
15. F. A. Troy, P. C. Hallenbeck, R. D. McCoy, and E. R. Vimr, "Detection of polysialosyl-containing glycoproteins in brain using prokaryotic-derived probes, "Methods in Enzymology, vol. 138, pp. 169-185, 1987.
16. G. Di Cristo, B. Chattopadhyaya, S. J. Kuhlman et al., "Activitydependent PSA expression regulates inhibitory maturation and onset of critical period plasticity, " Nature Neuroscience, vol. 10, no. 12, pp. 1569-1577, 2007.
17. L. D. Selemon, A. Begovic, P. S. Goldman-Rakic, and S. A. Castner, "Amphetamine sensitization alters dendritic morphology in prefrontal cortical pyramidal neurons in the non-human primate, " Neuropsychopharmacology, vol. 32, no. 4, pp. 919-931, 2007.
18. T. E. Robinson, G. Gorny, E. Mitton, and B. Kolb, "Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex, " Synapse, vol. 39, no. 3, pp. 257-266, 2001.
19. M. M. Morshedi, D. J. Rademacher, and G. E. Meredith, "Increased synapses in the medial prefrontal cortex are associated with repeated amphetamine administration, " Synapse, vol. 63, no. 2, pp. 126-135, 2009.
20. J. D. Elsworth, B. A. Morrow, T. Hajszan, C. Leranth, and R. H. Roth, "Phencyclidine-induced loss of asymmetric spine synapses in rodent prefrontal cortex is reversed by acute and chronic treatment with olanzapine, " Neuropsychopharmacology, vol. 36, no. 10, pp. 2054-2061, 2011.
21. H.-D. Wang, G. D. Stanwood, D. K. Grandy, and A. Y. Deutch, "Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamineD1 and D2 but not D4 receptor knockout mice, " Brain Research, vol. 1300, pp. 58-64, 2009.
22. A. F. T. Arnsten, "Stress signalling pathways that impair prefrontal cortex structure and function, " Nature Reviews Neuroscience, vol. 10, no. 6, pp. 410-422, 2009.
23. W.-D. Yao, R. D. Spealman, and J. Zhang, "Dopaminergic signaling in dendritic spines, " Biochemical Pharmacology, vol. 75, no. 11, pp. 2055-2069, 2008.
24. N. Santana, G. Mengod, and F. Artigas, "Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex, " Cerebral Cortex, vol. 19, no. 4, pp. 849-860, 2009.
25. X. Sun, Y. Zhao, and M. E. Wolf, "Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons, " The Journal of Neuroscience, vol. 25, no. 32, pp. 7342-7351, 2005.
26. E. A. Nimchinsky, B. L. Sabatini, and K. Svoboda, "Structure and function of dendritic spines, " Annual Review of Physiology, vol. 64, pp. 313-353, 2002.
27. S. Retaux, F. Trovero, and M. Besson, "Role of dopamine in the plasticity of glutamic acid decarboxylase messenger RNA in the rat frontal cortex and the nucleus accumbens, " European Journal of Neuroscience, vol. 6, no. 12, pp. 1782-1791, 1994.
28. L. Moutsimilli, S. Farley, S. Dumas, S. El Mestikawy, B. Giros, and E. T. Tzavara, "Selective cortical VGLUT1 increase as a marker for antidepressant activity, " Neuropharmacology, vol. 49, no. 6, pp. 890-900, 2005.
29. X.-J. Tan, Y.-B. Dai, W.-F. Wu et al., "Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 5, pp. 1708-1712, 2012.
30. B. J. Van Sickle, A. S. Cox, K. Schak, L. J. Greenfield Jr., and E. I. Tietz, "Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression, " Neuropharmacology, vol. 43, no. 4, pp. 595-606, 2002.
31. D. A. Velazquez-Zamora, M. M. Gonzalez-Ramirez, C. Beas- Zarate, and I. Gonzalez-Burgos, "Egocentric working memory impairment and dendritic spine plastic changes in prefrontal neurons afterNMDA receptor blockade in rats, " Brain Research, vol. 1402, pp. 101-108, 2011.
32. J. L. Brigman, T. Wright, G. Talani et al., "Loss of GluN2Bcontaining NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning, " The Journal of Neuroscience, vol. 30, no. 13, pp. 4590-4600, 2010.
33. C. S. Woolley and B. S. McEwen, "Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism, " The Journal of Neuroscience, vol. 14, no. 12, pp. 7680-7687, 1994.
34. M.-F. Xiao, J.-C. Xu, Y. Tereshchenko, D. Novak, M. Schachner, and R. Kleene, "Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization, " Journal ofNeuroscience, vol. 29, no. 47, pp. 14752-14763, 2009.
35. O. D. Howes and S. Kapur, "The dopamine hypothesis of schizophrenia: version III-the final common pathway, " Schizophrenia Bulletin, vol. 35, no. 3, pp. 549-562, 2009.
36. L. A. Glantz and D. A. Lewis, "Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia, " Archives of General Psychiatry, vol. 57, no. 1, pp. 65-73, 2000.
37. E. Monroy, E. Hernandez-Torres, and G. Flores, "Maternal separation disrupts dendritic morphology of neurons in prefrontal cortex, hippocampus, and nucleus accumbens in male rat offspring, " Journal of Chemical Neuroanatomy, vol. 40, no. 2, pp. 93-101, 2010.
38. A. Muhammad and B. Kolb, "Mild prenatal stress-modulated behavior and neuronal spine density without affecting amphetamine sensitization, " Developmental Neuroscience, vol. 33, no. 2, pp. 85-98, 2011.
39. M. P. Vawter, "Dysregulation of the neural cell adhesion molecule and neuropsychiatric disorders, " European Journal of Pharmacology, vol. 405, no. 1-3, pp. 385-395, 2000.
40. R. Tao, C. Li, Y. Zheng et al., "Positive association between SIAT8B and schizophrenia in the Chinese Han population, " Schizophrenia Research, vol. 90, no. 1-3, pp. 108-114, 2007.
41. D. Barbeau, J. J. Liang, Y. Robitalille, R. Quirion, and L. K. Srivastava, "Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains, " Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 7, pp. 2785-2789, 1995.
42. J. Gilabert-Juan, M. D. Molto, and J. Nacher, "Post-weaning social isolation rearing influences the expression of molecules related to inhibitory neurotransmission and structural plasticity in the amygdala of adult rats, " Brain Research, vol. 1448, pp. 129-136, 2012.
43. J. Gilabert-Juan, E. Varea, R. Guirado, J. M. Blasco-Ibanez, C. Crespo, and J. Nacher, "Alterations in the expression of PSANCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients, " Neuroscience Letters, vol. 530, no. 1, pp. 97-102, 2012.